Abstract

Treatment of obese (ob/ob) mice with the beta 3-adrenergic receptor (beta 3-AR) agonist BRL-35135 (1 mg.kg body wt-1.day-1 for 20 days) normalized plasma glucose levels and significantly decreased plasma insulin and nonesterified fatty acid levels. The time frame for the hypoglycemic effect, which reached a maximum after 10 days of treatment, paralleled an increase in brown adipose tissue DNA and protein content. The basal level of mRNA for the beta 3-AR and mitochondrial uncoupling protein was found to be markedly decreased in the ob/ob animals relative to the lean group. Chronic treatment of ob/ob mice for 20 days resulted in a twofold increase in beta 3-AR mRNA and a fivefold increase in uncoupling protein mRNA in brown adipose tissue relative to the placebo group. These findings indicate that chronic treatment of ob/ob animals with a beta 3-AR agonist results in proliferation of brown adipose tissue, with an upregulation of the beta 3-AR, which is associated with a decrease in plasma glucose, insulin, and nonesterified fatty acid levels.

Keywords

EndocrinologyInternal medicineUncoupling proteinAdipose tissueBrown adipose tissueAgonistInsulinReceptorChemistryThermogeninBETA (programming language)Downregulation and upregulationAdrenergic receptorBiologyMedicineGeneBiochemistry

Affiliated Institutions

Related Publications

Publication Info

Year
1995
Type
article
Volume
268
Issue
4
Pages
E678-E684
Citations
52
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

52
OpenAlex

Cite This

Cynthia Arbeeny, Daniel S. Meyers, D.E. Hillyer et al. (1995). Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice. American Journal of Physiology-Endocrinology and Metabolism , 268 (4) , E678-E684. https://doi.org/10.1152/ajpendo.1995.268.4.e678

Identifiers

DOI
10.1152/ajpendo.1995.268.4.e678